BHB
PPH icon

Bank Hapoalim BM’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bank Hapoalim BM’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Sell
2,299
-174
-7% -$18K 0.02% 105
2026
Q1 		$257K Sell
2,473
-121
-5% -$12.9K 0.04% 98
2025
Q4 		$268K Sell
2,594
-484
-16% -$47.1K 0.02% 98
2025
Q3 		$278K Sell
3,078
-870
-22% -$76.2K 0.03% 109
2025
Q2 		$347K Sell
3,948
-95
-2% -$8.23K 0.05% 101
2025
Q1 		$368K Sell
4,043
-100
-2% -$9.01K 0.05% 101
2024
Q4 		$357K Sell
4,143
-43,797
-91% -$3.96M 0.06% 110
2024
Q3 		$4.56M Sell
47,940
-750
-2% -$71.2K 0.69% 43
2024
Q2 		$4.45M Buy
48,690
+7,978
+20% +$712K 0.63% 45
2024
Q1 		$3.69M Buy
40,712
+35,339
+658% +$3.09M 0.48% 52
2023
Q4 		$437K Sell
5,373
-290
-5% -$22.7K 0.06% 119
2023
Q3 		$452K Sell
5,663
-6,810
-55% -$549K 0.07% 107
2023
Q2 		$982K Sell
12,473
-779
-6% -$61K 0.14% 101
2023
Q1 		$1.03M Sell
13,252
-1,723
-12% -$133K 0.14% 102
2022
Q4 		$1.16M Buy
14,975
+1,726
+13% +$127K 0.15% 94
2022
Q3 		$891K Buy
13,249
+739
+6% +$54.4K 0.11% 108
2022
Q2 		$961K Buy
12,510
+1,449
+13% +$113K 0.12% 114
2022
Q1 		$882K Buy
11,061
+2,105
+24% +$161K 0.09% 136
2021
Q4 		$689K Buy
+8,956
New +$666K 0.07% 150
2020
Q3 		– Sell
-7,297
Closed -$454K – 193
2020
Q2 		$454K Buy
7,297
+1,590
+28% +$96.1K 0.11% 118
2020
Q1 		$310K Sell
5,707
-1,818
-24% -$112K 0.1% 131
2019
Q4 		$483K Buy
+7,525
New +$453K 0.11% 111
2016
Q2 		– Sell
-3,489
Closed -$201K – 189
2016
Q1 		$201K Hold
3,489
– – 0.05% 152
2015
Q4 		$228K Hold
3,489
– – 0.05% 148
2015
Q3 		$220K Buy
+3,489
New +$245K 0.05% 144

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Bank Hapoalim BM's PPH Position: Q2 2026 in Review

Bank Hapoalim BM reduced its VanEck Pharmaceutical ETF (PPH) stake by 7% in Q2 2026, selling an estimated $18K and leaving 2,299 shares worth $251K. The position accounts for 0.02% of the portfolio, ranked #105.

Bank Hapoalim BM first reported a position in PPH in Q3 2015 and has held it in 25 quarters since. The position peaked at $4.56M in Q3 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Bank Hapoalim BM held 2,299 shares of VanEck Pharmaceutical ETF worth $251K as of Q2 2026.
  • Bank Hapoalim BM sold 174 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $18K.
  • VanEck Pharmaceutical ETF made up 0.02% of Bank Hapoalim BM's portfolio in Q2 2026, its #105 holding.
  • Bank Hapoalim BM first reported a position in VanEck Pharmaceutical ETF in Q3 2015 and has held it in 25 quarters since.
  • Bank Hapoalim BM's VanEck Pharmaceutical ETF position peaked at $4.56M in Q3 2024.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Bank Hapoalim BM's 13F filing for Q2 2026, filed 5 Aug 2026.